Hoff, Sabine,Röse, Lars,Zopf, Dieter,Kiessling, Fabian,Lederle, Wiltrud,Doleschel, Dennis
申请号：
AU2018276273
公开号：
AU2018276273A1
申请日:
2018.05.25
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
The present invention relates to pharmaceutical compositions and combinations comprising regorafenib or its hydrate, solvate, metabolite or pharmaceutically acceptable salt or a polymorph thereof and a PD-1/PD-L1(2) inhibitor for treating, preventing or managing diseases and conditions including hyperproliferative disorders such as cancer in humans and other mammals.
